Changes

Jump to: navigation, search

Influenza A

399 bytes added, 17:12, 20 December 2020
no edit summary
|NS, NPS direct, NPA(waived), NPW(not waived)
|N\A
|-|Remel/Thermo Fisher.<ref name="Arti23">XPECT™ RIDT Product Information, Remel/Thermo Fisher, https://www.thermofisher.com/document-connect/document-connect.html?url=https%3A%2F%2Fassets.thermofisher.com%2FTFS-Assets%2FMBD%2FInstructions%2FIFU24600%2520.pdf&title=WHBlY3QgRmx1IEEgYW5kIEI=</ref>|XPECT™ Flu A & BLABSCO|No|N/A|89-100%|100%|NW, NS|1.63*10<sup>3</sup>-4.41*10<sup>3</sup>
|}<div style="margin-bottom:1em"><sub>''Table 2: Selection of currently available systems for measuring adalimumab.''<br />*Note: the dilution ratio is defined as 1:x, with x the volume of added reagents relative to the volume of plasma sample</sub></div>

Navigation menu